Metagenomics Market (Product Type: Instruments, Kits & Reagents, and Software & Services; Technology: 16S Sequencing, Whole Genome Sequencing, Shotgun Sequencing, and Others; and Application: Ecology & Environment, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Beverages, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Metagenomics Analysis Platforms Play Pivotal Role in Matching COVID-19 Genomes

Economic activities in the metagenomics market are pacing up due to an unprecedented demand for COVID-19 (coronavirus) drug and vaccine discovery. Scientists have joined forces with metagenomics companies in order to provide tools and information that help if tackling the novel coronavirus. As such, companies in the metagenomics market are increasing their attention toward RNA sequencing-based data. Global leaders in next-generation sequencing services are adopting metagenomics detection of SARS-CoV-2 to effectively manage and analyze possible outcomes of the infection.

Metagenomics analysis platforms are gaining increased popularity in order to conduct metagenomics sequencing. Companies are experimenting with different algorithms for matching the closest genome to the novel coronavirus. They are conducting phylogenetic research to accelerate processes in the genomics community.

Metagenomics Sequencing Gold Standard for Diagnosis of Neuroinfectious Diseases

Metagenomics next generation sequencing is playing an instrumental role in the diagnosis of meningitis and encephalitis. The New England Journal of Medicine (NEJM) states that metagenomics sequencing is proving its utility in diagnosis of the most challenging cases of neuroinfectious diseases. Companies in the metagenomics market are increasing efforts to collect and analyze samples in real time in order to improve clinical outcomes.

A comprehensive read of the DNA and RNA in clinical samples is becoming possible with metagenomics sequencing. Companies in the metagenomics market are conducting bioinformatic comparison of the DNA and RNA samples with the publicly available databases to seek answers for agents responsible for the progression of neuroinfectious diseases. Metagenomics sequencing is being highly publicized in the healthcare landscape, since there is a high prevalence of infectious diseases that result in meningitis or encephalitis in individuals.

Metagenomics Market Segmentation

Drug Discovery and Soil Health Assessment Broaden Revenue Streams for Research Companies

The revenue of drug discovery is slated to witness huge leap from ~22% in 2019 and reach ~26% by the end of 2030 in the metagenomics market. Hence, research companies are adopting metagenomics medicine mapping systems in order to advance in the field of drug discovery. On the other hand, metagenomics is playing a pivotal role in the assessment of soil health and freshwater quality. These domains are broadening revenue streams for companies in the metagenomics market. Unprecedented environmental events and impact on the biodiversity are key drivers favoring market growth.

Innovative Bioinformatics Tools Help Overcome Bottlenecks of Complex Unassembled Reads

Apart from drug discovery and clinical diagnostics, companies in the metagenomics market are increasing their focus in food genomics in order to broaden their revenue streams. As such, food & beverages are estimated to dictate the third-highest revenue among all applications in the metagenomics market. The growing demand for safe food production and preservation is creating incremental opportunities for companies in the market for metagenomics.

Striking the right balance between food enzymes and microbes is becoming the key focus point for research labs and healthcare companies in order to ensure safe food production and preservation. Hence, companies are increasing their R&D activities in food microbiology. As stated by molecular biologist Dr. Nur Hasan from CosmosID - a leading next generation sequencing services company, placing together complex unassembled reads and the lack of comprehensive databases are some of the bottlenecks that researchers face in the field of food quality and safety. Hence, providers of end-to-end microbiome platforms are increasing efforts to develop integrated platforms with innovative bioinformatics tools that facilitate ultra-fast metagenomics analysis.

Analysts’ Viewpoint

The automated placement of COVID-19 with closest known viruses is being made possible with next-gen metagenomics analysis platforms. Microbial ecologists in the metagenomics market are extensively using shotgun metagenomics to assess the microbial diversity in soil. However, limited sequence assembly from highly complex samples poses a bottleneck for microbial ecologists. Hence, companies should increase awareness about flow cytometry-enabled mini-metagenomics to help microbial ecologists capture expanded microbial diversity from forest soil.

Metagenomic sequencing holds potential in the diagnosis of neuroinfectious diseases. Bioinformatics technologies are being deployed for the study of plant-associated microbial communities. Integrated bioinformatics tools are playing a key role in meeting specificity requirements in food safety applications.

Metagenomics Market: Overview

The global metagenomics market was valued at US$ 1.3 Bn in 2019. It is projected to expand at a high CAGR from 2020 to 2030. Rapid expansion of the life sciences industry, increase in the number of clinical and diagnostics laboratories, adoption of metagenomics sequencing, rise in application of metagenomics study in genomics & proteomics, and shift in focus on research & development are anticipated to augment the global metagenomics market during the forecast period.

Technological advancements leading to development of sequencer instruments and availability of data analysis software with presence of various small bioinformatics companies are expected to propel the global metagenomics market

Metagenomics is a considered to be molecular tool utilized for analysis of the DNA acquired from environmental samples. Metagenomics is the study of the metagenome, the collective genome of microorganisms, from an environmental sample to provide information on the microbial diversity and ecology of a specific environment. Metagenomics is considered to be a modern approach for genomic analysis. This process is time consuming; however, it offers promising possibilities to discover novel genes and biomolecules.

Environmental samples include samples from water, soil, and feces. Human microbiomes are also used in metagenomics study for analysis of complex microbes. Metagenomics have wide applications in the fields of ecology & environment, drug discovery, clinical diagnostics, and food & beverages. Major steps in the metagenomic study includes sampling, sequencing, sequence read processing, assembly, gene prediction, binning, and functional annotation. Various types of metagenomic sequencings are used in metagenomics such as 16S sequencing, whole genome sequencing, and shotgun sequencing.

Metagenomics Market: Segmentation

The global metagenomics market has been segmented based on product type, technology, application, and region

In terms of product type, the global metagenomics market has been classified into instruments, kits & reagents, and others. The instruments segment accounted for a notable share of the market, owing to the instruments used as a primary tools for conducting metagenomic study, as these allow to run samples for further extraction of DNA and displaying the result. Presence of key players are estimated to boost the metagenomics market during the forecast period. Companies such as Illumina Inc., Eurofins Genomics, and Qiagen offers advanced sequencing system to conduct metagenomics study.

Based on technology, the global metagenomics market has been categorized into 16S sequencing, whole genome sequencing, shotgun sequencing, and others. The 16S sequencing segment accounted for a prominent share of the market in 2019, as it is a highly suitable technology used for DNA sequencing from complex different species samples.

 In terms of application, the global metagenomics market has been divided into ecology & environment, clinical diagnostics, drug discovery, biotechnology, food & beverages, and others. The clinical diagnostics segment dominated the global metagenomics market in 2019, owing to the usage of the shotguns sequencing metagenomics in the detection and screening of pathogen in clinical samples.

Metagenomics Market: Regional Segmentation

In terms of region, the global metagenomics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America dominated the global metagenomics market in 2019, attributable to technological advancements, higher adoption rate of metagenomics sequencing, which includes shotgun sequencing, advanced research & development in the region, prevalence of pandemic COVID 19 and other diseases, and wide application of metagenomics study for clinical diagnostics and drug discovery. illumina Inc. is a prominent player and leader that offers next-generation sequencing products across globe. The strong product offerings is another factor that is estimated to fuel the market in the region during the forecast period.

Europe was the second-largest market for metagenomics globally in 2019. Europe accounted for a leading share of the global market in 2019. According to The Community Research and Development Information Service (CORDIS), increase in EU initiatives for transforming the Research Network in Biodiversity and Evolutionary Biology (InBIO) in Portugal into a hub for top-level research in metagenomics is a major factor boosting the market in Europe. Adoption of bioinformatics tools in metagenomics analysis is expected to drive the market in the region.

Metagenomics Market: Major Players

• Key players operating in the global metagenomics market include 
• Thermo Fisher Scientific, Inc.
• QIAGEN
• Illumina, Inc.
• Promega Corporation
• Novogene Co., Ltd.
• Takara Bio, Inc
• Oxford Nanopore Technologies
• Arc Bio, LLC.
• Eurofins Scientific
• Zymo Research
• Microsynth AG
• F. Hoffmann-La Roche Ltd. (Roche Sequencing)
•  PerkinElmer, Inc.
• Computomics GmbH.

Key players are focused on adopting various strategies to expand their product offerings and strengthen geographic presence across the globe. Key players have incorporated diverse strategies such as mergers & acquisitions, launching new metagenomics sequencer, and adoption of the shotgun sequencing technology, which, in turn, are estimated to propel the global metagenomics market.

Key Questions Answered in Metagenomics Market Report

• What is the sales/revenue generated by the global metagenomics market across all the regions during the forecast period?
• What are the key trends in the global metagenomics market?
• What are the major drivers, restraints, and opportunities in the global market?
• Which region is set to expand at the fastest CAGR during the forecast period?
• Which segment will have the highest revenue globally in 2030 and which product type, and technology will expand at the fastest CAGR during the forecast period?

Metagenomics Market - Segmentation

Product Type

• Instruments
• Kits & Reagents
• Software & Services

Technology

• 16S Sequencing
• Whole Genome Sequencing
• Shotgun Sequencing
• Others

Application

• Ecology & Environment
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Food & Beverages
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

1. Preface

    1.1. Market  Definition and Scope

    1.2. Market  Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metagenomics Market  

4. Market  Overview

    4.1. Introduction

        4.1.1. Market  Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market  Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Metagenomics Market Analysis and Forecast, 2018–2030

        4.4.1. Market  Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industry Events and Developments

    5.2. Major Research Institutes Involved

    5.3. Pricing Analysis

    5.4. Technological Advancements

    5.5. COVID-19 Pandemic Impact on Global Metagenomics Market

6. Global Metagenomics Market Analysis and Forecast, by Product Type   

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Metagenomics Market Value Forecast, by Product Type, 2018–2030

        6.3.1. Instruments 

        6.3.2.  Kits & Reagents 

        6.3.3. Software & Services 

    6.4. Market Attractiveness Analysis, by Product Type 

7.   Global Metagenomics Market Analysis and Forecast, by Technology 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Metagenomics Market Value Forecast, by Technology, 2018–2030

        7.3.1. 16S Sequencing 

        7.3.2. Whole Genome Sequencing 

        7.3.3. Shotgun Sequencing

        7.3.4. Others

    7.4. Global Metagenomics Market Attractiveness Analysis, by Technology 

8. Global Metagenomics Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Metagenomics Market Value Forecast, by Application, 2018–2030

        8.3.1. Ecology & Environment 

        8.3.2. Clinical Diagnostics

        8.3.3. Drug Discovery

        8.3.4. Biotechnology

        8.3.5. Food & Beverage

        8.3.6. Others 

    8.4. Global Metagenomics Market Attractiveness Analysis, by Application

9. Global Metagenomics Market Analysis and Forecast, by Region 

    9.1. Key Findings

    9.2. Global Metagenomics Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe 

        9.2.3. Asia Pacific

        9.2.4. Latin America 

        9.2.5. Middle East & Africa

    9.3. Global Metagenomics Market Attractiveness Analysis, by Region

10. North America   Metagenomics Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2.  North America Metagenomics Market Value Forecast, by Product Type, 2018–2030

        10.2.1. Instruments 

        10.2.2. Kits & Reagents 

        10.2.3. Software & Services 

    10.3. North America Metagenomics Market Value Forecast, by Technology, 2018–2030

        10.3.1. 16S Sequencing 

        10.3.2. Whole Genome Sequencing 

        10.3.3. Shotgun Sequencing

        10.3.4. Others

    10.4. North America Metagenomics Market Value Forecast, by Application, 2018–2030

        10.4.1. Ecology & Environment 

        10.4.2. Clinical Diagnostics

        10.4.3. Drug Discovery

        10.4.4. Biotechnology

        10.4.5. Food & Beverage

        10.4.6. Others 

    10.5. North America Metagenomics Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Metagenomics Market Attractiveness Analysis

        10.6.1. By Product Type   

        10.6.2. By Technology 

        10.6.3. By Application   

        10.6.4. By Country

11. Europe  Metagenomics Market Analysis and Forecast

    11.1.  Introduction

        11.1.1.  Key Findings

    11.2. Europe Metagenomics Market Value Forecast, by Product Type, 2018–2030

        11.2.1. Instruments 

        11.2.2. Kits & Reagents 

        11.2.3. Software & Services 

    11.3. Europe Metagenomics Market Value Forecast, by Technology, 2018–2030

        11.3.1. 16S Sequencing 

        11.3.2. Whole Genome Sequencing 

        11.3.3. Shotgun Sequencing

        11.3.4. Others

    11.4. Europe Metagenomics Market Value Forecast, by Application, 2018–2030

        11.4.1. Ecology & Environment 

        11.4.2. Clinical Diagnostics

        11.4.3. Drug Discovery

        11.4.4. Biotechnology

        11.4.5. Food & Beverage

        11.4.6. Others 

    11.5. Europe Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Metagenomics Market Attractiveness Analysis

        11.6.1. By Product Type   

        11.6.2. By Technology 

        11.6.3. By Application   

        11.6.4. By Country/Sub-region

12. Asia Pacific Metagenomics Market Analysis and Forecast

    12.1.  Introduction

        12.1.1.  Key Findings

    12.2. Asia Pacific Metagenomics Market Value Forecast, by Product Type, 2018–2030

        12.2.1. Instruments 

        12.2.2. Kits & Reagents 

        12.2.3. Software & Services 

    12.3. Asia Pacific Metagenomics Market Value Forecast, by Technology, 2018–2030

        12.3.1. 16S Sequencing 

        12.3.2. Whole Genome Sequencing 

        12.3.3. Shotgun Sequencing

        12.3.4. Others

    12.4. Asia Pacific Metagenomics Market Value Forecast, by Application, 2018–2030

        12.4.1. Ecology & Environment 

        12.4.2. Clinical Diagnostics

        12.4.3. Drug Discovery

        12.4.4. Biotechnology

        12.4.5. Food & Beverage

        12.4.6. Others 

    12.5. Asia Pacific Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India 

        12.5.4. Australia & New Zealand 

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Metagenomics Market Attractiveness Analysis

        12.6.1. By Product Type   

        12.6.2. By Technology 

        12.6.3. By Application   

        12.6.4. By Country/Sub-region

13. Latin America Metagenomics Market Analysis and Forecast

    13.1.  Introduction

        13.1.1.  Key Findings

    13.2. Latin America Metagenomics Market Value Forecast, by Product Type, 2018–2030

        13.2.1. Instruments 

        13.2.2. Kits & Reagents 

        13.2.3. Software & Services 

    13.3. Latin America Metagenomics Market Value Forecast, by Technology, 2018–2030

        13.3.1. 16S Sequencing 

        13.3.2. Whole Genome Sequencing 

        13.3.3. Shotgun Sequencing

        13.3.4. Others

    13.4. Latin America Metagenomics Market Value Forecast, by Application, 2018–2030

        13.4.1. Ecology & Environment 

        13.4.2. Clinical Diagnostics

        13.4.3. Drug Discovery

        13.4.4. Biotechnology

        13.4.5. Food & Beverage

        13.4.6. Others 

    13.5. Latin America Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Metagenomics Market Attractiveness Analysis

        13.6.1. By Product Type   

        13.6.2. By Technology 

        13.6.3. By Application   

        13.6.4. By Country/Sub-region

14. Middle East & Africa Metagenomics Market Analysis and Forecast

    14.1.  Introduction

        14.1.1.  Key Findings

    14.2. Middle East & Africa Metagenomics Market Value Forecast, by Product Type, 2018–2030

        14.2.1. Instruments 

        14.2.2. Kits & Reagents 

        14.2.3. Software & Services 

    14.3. Middle East & Africa Metagenomics Market Value Forecast, by Technology, 2018–2030

        14.3.1. 16S Sequencing 

        14.3.2. Whole Genome Sequencing 

        14.3.3. Shotgun Sequencing

        14.3.4. Others

    14.4. Middle East & Africa Metagenomics Market Value Forecast, by Application, 2018–2030

        14.4.1. Ecology & Environment 

        14.4.2. Clinical Diagnostics

        14.4.3. Drug Discovery

        14.4.4. Biotechnology

        14.4.5. Food & Beverage

        14.4.6. Others 

    14.5. Middle East & Africa Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries 

        14.5.2. South Africa 

        14.5.3. Rest of Middle East & Africa

    14.6.  Middle East & Africa Metagenomics Market Attractiveness Analysis

        14.6.1. By Product Type   

        14.6.2. By Technology 

        14.6.3. By Application   

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market  Player – Competition Matrix (By Tier and Size of companies)

    15.2.  Company Profiles

        15.2.1. Thermo Fisher Scientific, Inc. 

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Financial Overview

            15.2.1.3. Product Portfolio

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. QIAGEN

            15.2.2.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Financial Overview

            15.2.2.3. Product Portfolio

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. Illumina, Inc.

            15.2.3.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Financial Overview

            15.2.3.3. Product Portfolio

            15.2.3.4. Strategic Overview

            15.2.3.5. SWOT Analysis

        15.2.4. Promega Corporation 

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Product Portfolio

            15.2.4.3. Strategic Overview

            15.2.4.4. SWOT Analysis

        15.2.5. Novogene Co., Ltd. 

            15.2.5.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

        15.2.6. Takara Bio, Inc. 

            15.2.6.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Financial Overview

            15.2.6.3. Product Portfolio

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. Oxford Nanopore Technologies

            15.2.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Product Portfolio

            15.2.7.3. Strategic Overview

            15.2.7.4. SWOT Analysis

        15.2.8.  Arc Bio, LLC. 

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Product Portfolio

            15.2.8.3. Strategic Overview

            15.2.8.4. SWOT Analysis

        15.2.9. Eurofins Scientific 

            15.2.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Financial Overview

            15.2.9.3. Product Portfolio

            15.2.9.4. Strategic Overview

            15.2.9.5. SWOT Analysis

        15.2.10. Zymo Research

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Product Portfolio

            15.2.10.3. Strategic Overview

            15.2.10.4. SWOT Analysis

        15.2.11. Microsynth AG 

            15.2.11.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.2.11.2. Product Portfolio

            15.2.11.3. Strategic Overview

            15.2.11.4. SWOT Analysis

        15.2.12. F. Hoffmann-La Roche Ltd. (Roche Sequencing) 

            15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.12.2. Financial Overview

            15.2.12.3. Product Portfolio

            15.2.12.4. Strategic Overview

            15.2.12.5. SWOT Analysis

        15.2.13. PerkinElmer, Inc.  

            15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.13.2. Financial Overview

            15.2.13.3. Product Portfolio

            15.2.13.4. Strategic Overview

            15.2.13.5. SWOT Analysis

        15.2.14. Computomics GmbH 

            15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.14.2. Product Portfolio

            15.2.14.3. Strategic Overview

            15.2.14.4. SWOT Analysis